Why did the FTSE 100 fall for the seventh time in eight sessions, and what key factors were driving investor sentiment on Wednesday?

The FTSE 100 dipped 0.7% by 0950 GMT on Wednesday, slipping for the seventh time in eight sessions, as investors digested mixed corporate earnings and awaited major global central bank decisions—including the Bank of England’s upcoming policy announcement. Key drivers included downward pressure from major stocks: AstraZeneca fell 1.4% and GSK dropped 2.1% despite both reaffirming full-year forecasts and posting better-than-expected quarterly profits; Lloyds Banking Group declined 1.4% even after reporting a better-than-expected rise in first-quarter profit. Earnings season was unfolding amid heightened caution over potential spillover effects from the ongoing Iran war, which remained at an impasse—with U.S. President Donald Trump rejecting Tehran’s latest proposal due to his insistence on addressing nuclear issues upfront. Simultaneously, markets were bracing for the Federal Reserve meeting later that day and earnings releases from U.S. megacaps Alphabet, Microsoft, Meta, and Amazon, all expected to influence broader market tone. Geopolitical uncertainty remained elevated, prompting the Bank of England to be widely expected to hold interest rates steady on Thursday. Although tentative hopes for a U.S.-Iran war resolution had helped stabilize the FTSE 100—putting it on track for a marginal April gain after its worst monthly slump in six years—the persistent earnings ambiguity and geopolitical stalemate continued to weigh on sentiment.

What triggered DCC’s 16% surge, and how does it contrast with the broader market trend?

DCC surged 16% after announcing it was reviewing a cash takeover proposal from a consortium of U.S. investment firms Energy Capital Partners and KKR—a sharp positive catalyst amid otherwise broad-based weakness across UK equities. This stood in stark contrast to the wider market trend: the FTSE 100 fell 0.7%, marking its seventh decline in eight sessions, while the FTSE 250 edged down 0.1%; major blue-chip stocks including AstraZeneca, GSK, and Lloyds all declined despite delivering stronger-than-expected quarterly profits and maintaining full-year guidance. DCC’s rally thus reflected company-specific M&A momentum rather than improved macro or sectoral conditions, highlighting how isolated positive developments can temporarily override prevailing negative sentiment driven by mixed earnings, geopolitical risk (particularly the stalled U.S.-Iran negotiations), and anticipation of pivotal central bank decisions—including the Bank of England’s imminent rate decision and the U.S. Federal Reserve’s meeting later the same day.

London Stocks Slip as Investors Parse Mixed Earnings Bag

Apr 29, 2026

UK shares declined as traders digested mixed corporate earnings, with pharmaceutical giants AstraZeneca and GSK falling despite strong profit forecasts amidst geopolitical tensions.

reuters

2026-04-29

London Stocks Slip as Investors Parse Mixed Earnings Bag

London Stocks Slip as Investors Parse Mixed Earnings Bag

FAQ